Summary
Gilead Sciences, Inc. (GILD) announced on January 25, 2011, that its Board of Directors has authorized a significant new stock repurchase program. This program allows for the repurchase of up to $5.0 billion of the company's common stock. The repurchase will be executed through various methods, including open market transactions, private block transactions, and potentially accelerated stock repurchases. This initiative signals strong financial confidence from Gilead's management and is intended to return value to shareholders. The new program is set to commence immediately following the completion of the previously authorized $5.0 billion repurchase program from May 2010, and will continue for three years thereafter. Investors should view this as a positive indicator of the company's financial health and its commitment to enhancing shareholder returns.
Key Highlights
- 1Gilead Sciences authorized a new stock repurchase program of up to $5.0 billion.
- 2The repurchase will be executed through open market and private block transactions, including accelerated stock repurchases.
- 3This new program is a signal of strong financial health and management confidence.
- 4The repurchase plan will commence upon completion of the existing $5.0 billion program approved in May 2010.
- 5The new program has an end date set for the third anniversary of its commencement.
- 6This initiative is aimed at returning value to shareholders.